Tivozanib showed 44% improvement in progression free survival and 26% reduction in risk of progression or death compared to sorafenib (Image: AVEO Pharmaceuticals)
It’s been a pretty wild year for the health care sector. Public attention was captured by the relatively disastrous rollout of Obamacare’s exchanges, and the plethora of opinions that
At www.ValuEngine.com we show that the Medical sector 10.6% overvalued with the Medical Biomed / Genetics 12.3% overvalued. All 16 stocks in today’s table have complete ValuEngine data and have
U.S. Retail Sales posted their largest gain in five months in February. Total retail sales increased 1.1% percent (after a 0.6% rise in January). According to ICSC-Goldman, the same-store sales
Investing in small-cap stocks can be a real crap shoot. While larger, blue-chips have a certain stability connected to their size, small-cap companies can experience much larger swings up and
The International trade balance rose to $48.8 billion in December. The Michigan Consumer Sentiment Survey came in weaker than expected at 72.5. The Dow Jones Industrial Average opened lower and
